Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Rheumatic Diseases × halofantrine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Papillomavirus Infections 2 Neoplasms 2 Liver Neoplasms 2 Liver Diseases 2 Carcinoma, Hepatocellular 2 Virus Diseases 1 Uterine Cervical Neoplasms 1 Stomach Neoplasms 1 Rheumatic Diseases 1 Primary Graft Dysfunction 1 Liver Failure, Acute 1 Liver Failure 1 HIV Infections 1 Gastrointestinal Neoplasms 1 Digestive System Neoplasms 1 Digestive System Diseases 1 Adenocarcinoma 1

Interventions

pandemrix 1 lactitol 1 halofantrine 1 focetria 1 Vaccines 1 COVID-19 Vaccines 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01022905 2010-03-01

Vaccine Responses to Influenza A H1N1/09 Immunization in High-risk Patients

University Hospital, Geneva

Phase 4 Completed

Neoplasms, Rheumatic Diseases, HIV Infections

Data powered by HemOnc (CC BY 4.0) Colophon ⚡